Finance Dnca

Holdings History for BIOMARIN PHARMACEUTICAL INC - NOTE 1.250% 5/1

Investment type: Debt / NOTE 1.250% 5/1

Shares, Excluding Options vs Price

Value, Excluding Options

Holdings date	Weight	Change	Value $	Principal	Change	Activity %	Price	All Holders
30 Jun 2025		-0.04%	$0	0	-450,000	-100%	95.8%	Q2 2025
31 Mar 2025	0.04%	0%	$427,177	450,000	0		94.93%	Q1 2025
31 Dec 2024	0.03%	0%	$419,727	450,000	0		93.27%	Q4 2024
30 Sep 2024	0.04%	0%	$431,058	450,000	0		95.79%	Q3 2024
30 Jun 2024	0.04%	0%	$431,640	450,000	0		95.92%	Q2 2024

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.